Adrianus G. Van Roon

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: A Systematic Narrative Review.

The Role of Interleukin-4 and Interleukin-10 in Osteoarthritic Joint Disease: A Systematic Narrative Review.

Journal: Cartilage

Published: May 13, 2022

Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial.

Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial.

Journal: The Lancet. Rheumatology

Published: January 08, 2020

IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.

IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.

Journal: Clinical and experimental immunology

Published: September 20, 2018

Optimizing conventional DMARD therapy for Sjögren's syndrome.

Optimizing conventional DMARD therapy for Sjögren's syndrome.

Journal: Autoimmunity reviews

Published: December 02, 2017

IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.

IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.

Journal: Osteoarthritis and cartilage

Published: October 23, 2017

High soluble IL-7 receptor expression in Sjögren's syndrome identifies patients with increased immunopathology and dryness.

High soluble IL-7 receptor expression in Sjögren's syndrome identifies patients with increased immunopathology and dryness.

Journal: Annals of the rheumatic diseases

Published: January 20, 2016

Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.

Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 07, 2015

Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond.

Aging and Systemic Lupus Erythematosus - Immunosenescence and Beyond.

Journal: Current aging science

Published: May 24, 2015

The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.

The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 14, 2014

Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.

Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.

Journal: Annals of the rheumatic diseases

Published: February 08, 2012

IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage.

IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage.

Journal: Osteoarthritis and cartilage

Published: January 18, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026